The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.
MilliporeSigma has signed an agreement with HistoCyte Laboratories, a Tyne, UK-based cell-line technology company, to be the exclusive multinational distributor of HistoCyte’s portfolio of cell-line reference products for immunohistochemistry and...
Minakem, the contract development and manufacturing division of Minafin, a Mont-Saint-Guibert, Belgium-based fine chemicals producer, plans to open a new closed-controlled environment high-containment production facility in August 2018 at the...
Marken, a Research Triangle Park, North Carolina-based provider of logistics and supply-chain services for clinical trial materials, is relocating its Chicago logistics hub into a new, larger facility near the Chicago airport.
The new full-service...
Recipharm, a Jordbro, Sweden-based contract development and manufacturing organization, has divested its rights, except in the US, for a potassium iodide product, ThyroSafe, to SERB SA, a Brussels, Belgium-headquartered specialty pharmaceutical...
Sarepta Therapeutics, a Cambridge, Massachusetts-based biopharmaceutical company focused on RNA-targeted therapeutics for rare neuromuscular diseases, has formed a long-term manufacturing partnership for gene-therapy with Brammer Bio, a Lexington,...
Recipharm, a Jordbro, Sweden-based contract development and manufacturing organization, has agreed to acquire Sanofi’s contract manufacturing business for respiratory products in Holmes Chapel, England for approximately $60 million.
The business...
Thermo Fisher Scientific has opened a US Precision Medicine Science Center (PMSC) in Cambridge, Massachusetts. The center offers access to technologies to help collaborators develop analytical workflows that generate precise molecular profiles of...
AMRI, a contract research, development, and manufacturing organization, has signed a seven-year contract with the National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes of Health (NIH), to manufacture active...
WuXi Biologics, part of WuXi AppTec, a Shanghai, China-headquartered contract service provider, plans to invest $60 million to establish a biologics clinical and commercial manufacturing facility in Worcester, Massachusetts. The facility will be...
Cambrex, an East Rutherford, New Jersey-based contract manufacturer of small-molecule active pharmaceutical ingredients (APIs), plans to expand research and development (R&D) capabilities at its site in Paullo, Milan, Italy.
The company is...
Vetter Pharma, a Ravensburg, Germany-headquartered contract development and manufacturing organization for aseptic filling and final packaging of injectables, has launched a challenge for developing solutions for injectables medicines that are...
Wasdell Group, a Newcastle, UK-headquartered contract development and manufacturing organization and contract packager, plans to invest £500,000 ($668,000) in a new analytical laboratory at its Newcastle site.
The 1,200 square-foot facility will...
GE Healthcare has partnered with Xiangxue Pharmaceutical Co., a Guangzhou, China-headquartered pharmaceutical company, to provide GE’s FlexFactory platform, a semi-automated end-to-end manufacturing platform, to help scale up, digitize and...
Catalent Pharma Solutions reports on its supply pact with InterveXion, a Little Rock, Arkansas-headquartered clinical-stage biopharmaceutical company, to support the production of IXT-m200, InterveXion’s investigational anti-methamphetamine...
Cambrex, an East Rutherford, New Jersey-based contract manufacturer of small-molecule active pharmaceutical ingredients (APIs), plans to begin a $5-million expansion of laboratory facilities at its site in Karlskoga, Sweden.
The company is...
